Catalyst Wire Dossier Catalyst Wire Dossier

Probiotic ES1

· Exzell Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Probiotic ES1, covering 2016-10-07 to 2016-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity [Phase 2]

See pricing